Marketable Securities, Current in USD of Protara Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Protara Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2021 to Q3 2025.
  • Protara Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $120M, a 304% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Protara Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $120M +$90.4M +304% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $90.7M Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $32.9M +$29.9M +1000% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $7.49M -$18.5M -71.2% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $29.7M -$10.5M -26.1% Sep 30, 2024 10-Q 2024-11-12
Q1 2024 $2.99M -$62.6M -95.4% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $26M -$34.2M -56.9% Dec 31, 2023 10-K 2025-03-05
Q3 2023 $40.3M -$8.55M -17.5% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $46.4M -$18.3M -28.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $65.6M +$3.42M +5.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $60.2M +$4.74M +8.54% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $48.8M -$4.2M -7.92% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $64.6M +$26.8M +70.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $62.2M +$36M +138% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $55.5M Dec 31, 2021 10-K 2023-03-08
Q3 2021 $53M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $37.8M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $26.1M Mar 31, 2021 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.